To investigate the role of NF-κB/p52 in regulating the genomic occupancy of ETS1 in gliomas, we performed chromatin immunoprecipitation (ChIP) sequencing (ChIP-seq) using p52 and ETS1 antibodies in the glioma cell line, U-87 MG, with and without TWEAK treatment. The gene discussed is NFKB1; the disease is central nervous system cancer.